|By Marketwired .||
|August 8, 2013 09:01 AM EDT||
TORONTO, ONTARIO -- (Marketwired) -- 08/08/13 -- Prism Medical Ltd. ("Prism Medical" or the "Company") (TSX VENTURE:PM), a leading provider of durable medical equipment and related services to the mobility challenged, announced today that it has been granted conditional approval from the TSX Venture Exchange Inc. to amend certain stock option agreements affecting options to acquire 247,000 common shares at prices ranging from $4.72 to $5.20, by extending the expiry dates to May 31, 2014. The reason for the amendment is that the Company's stock option plan does not allow for automatic extensions of the "expiry date" of options if the expiry date occurs during a "blackout" period pursuant to the Company's securities trading policy. As a result the optionees may not be able to exercise outstanding options. The Company intends to present an amendment to the stock option plan addressing this issue for approval by the shareholders at the next annual meeting to be held prior to the end of May, 2014.
About Prism Medical Ltd.
Prism Medical Ltd. is one of the largest providers and manufacturers of durable medical equipment and related services to the mobility challenged in Canada, the US and the UK, with more than 100,000 installations and 200,000 product solutions sold. The Prism Medical brands include Waverley Glen and ErgoSafe, North America's leading supplier of lifting, handling and repositioning aid products and services across Canada and the US. Freeway and Prism Service & Repair are leading suppliers of moving and handling products and services in the UK. For further information visit Prism Medical's website at www.prismmedicalltd.com or www.sedar.com.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.